Another study highlighted that overexpression of FSTL3 impacts CRC prognosis and can promote epithelial-to-mesenchymal transition (EMT) and aerobic glycolysis via the activated β-catenin pathway, thereby affecting CRC cell invasiveness and metastatic capability [36]. Here, FSTL3 is linked to colorectal carcinoma.